Start-Up Snapshot: SynCath Neuroscience Addresses Brain Edema
Medtech Insight attended the OurCrowd Global Investor Summit in Jerusalem, Israel on February 13. At the meeting, Ofer Barnea, CEO of neurosurgery start-up SynCath Neuroscience, explained his company’s device to treat cerebral edema,
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.